Firefly Stock Jumps On Department Of Defense Partnership

Firefly Neuroscience, Inc. (NASDAQ: AIFF) shares surged 38.69% to $2.33 following the announcement of a public-private partnership with the Department of Defense. This partnership aims to support the assessment and treatment of U.S. service members and veterans suffering from PTSD and traumatic brain injuries using Firefly's FDA-cleared, AI-powered EEG/ERP platform. The collaboration is expected to expand Firefly's commercial presence in the U.S. government and defense health sectors.